新「政院女神」戀愛感甜笑亮相 網曝學霸背景

新「政院女神」戀愛感甜笑亮相 網曝學霸背景

2019/12/13 11:48

〔即時新聞／綜合報導〕政壇新生代輩出，且不乏有高顏值、高學經歷的帥哥美女，近日有民眾發現，行政院發言人谷辣斯・尤達卡（Kolas Yotaka）身邊替她翻頁的小幕僚，笑容甜美加上日系扮相，讓網友們不禁說有「戀愛的感覺！」更有鄉民翻出她高普考雙料榜首的學霸背景！

綜合媒體報導，有民眾近日在批踢踢表特版（PTT Beauty）上PO出「笑容很甜美的女孩兒」，並附上新聞畫面，寫說「似乎是行政院發言人的幕僚」，還附上許多日常生活照，有網友看到則表示，贏過台北市的學姊（黃瀞瑩），還有人表示她的笑容「讓人有戀愛的感覺～」

這名幕僚甜美亮相之後，鄉民更封她為「政院女神」，還有人說想親赴行政院「朝聖」，不僅如此更有鄉民翻出她的驚人學霸背景，就是105年度高普考三等新聞行政及普考新聞行政雙榜首張瑜芳，目前在行政院新聞傳播處擔任幕僚。

而張瑜芳以前在批踢踢國考版（PTT Examination）分享上榜心得的文章，也被網友翻出來，文中寫及她大學和研究所皆就讀台灣大學，多益940分、托福iBT考取98分，驚人的是她當時下定決心「五個月就考上！」最後拿下雙榜首。不過張瑜芳也在寫到，在準備國考時壓力特別大，導致內分泌失調，甚至還有掉髮現象。

對於這名「政院女神」，谷辣斯・尤達卡表示，她是「辦公室的甜心！」並說大家都愛她，不僅溫柔，工作很有效率，而且平時做事非常認真，非常Sweet。谷辣斯・尤達卡還說，張瑜芳大約是今年後半年調來行政院發言人室，也說她的到來，為辦公室帶來許多鮮活的氣氛以及甜蜜的感覺。

不用抽 不用搶 現在用APP看新聞 保證天天中獎 點我下載APP 按我看活動辦法

Use of PKG Device in Parkinson’s Shown to Detect Abnormal Movements

The Parkinson’s Personal KinetiGraph (PKG), a small motion sensor device that can be worn on the wrist like a watch in patients with Parkinson’s disease, can be used to detect abnormal movements, especially those associated with bradykinesia at the earlier stages of the disorder, an observational study has found.

The study, “More Sensitive Identification for Bradykinesia Compared to Tremors in Parkinson’s Disease Based on Parkinson’s KinetiGraph (PKG),” was published in the journal Frontiers in Aging Neuroscience.

Slowness or difficulty performing certain movements, also known as bradykinesia, is one of the earlier motor symptoms of Parkinson’s.

The PKG is a motion sensor device developed by Global Kinetics that has been approved by the FDA to measure and monitor several motor symptoms of Parkinson’s, including tremors, bradykinesia, and involuntary movements known as dyskinesia. It is worn on the wrist of the individual’s most affected side.

Once placed on the wrist, the device not only continuously measures these motor parameters — it also can be used to set reminders on when patients should take their medications, particularly levodopa.

The PKG watch also can indicate the relationship between medication and symptoms, “which is conducive to adjusting drugs, monitoring disease development, optimizing levodopa medication, and controlling the daily dose of levodopa, which may prevent sports complications,” the researchers wrote.

The team noted that “prevention of sports complications is important,” and that the factors for such difficulties due to Parkinson’s include age of disease onset, its severity, and the dose of medication given.

Now, the researchers reported the findings of an observational study that aimed to determine how well the data picked up by the PKG motion sensor device matched other clinical score measures of Parkinson’s motor symptoms.

Additionally, the team also sought to determine if the PKG motion sensor device would be suitable to detect early motor symptoms associated with the disease.

The observational study involved a total of 100 patients — 60 men and 40 women, with an average age of 66 — and was carried out in Fuzhou, China. Among the participants, 35 were at the early stages of the disease (Hoehn and Yahr stage 1–2), and 65 at an intermediate-to-advanced stage of Parkinson’s (Hoehn and Yahr stage 2.5–5).

During the study, participants were instructed to wear the PKG device continuously for at least six days. The researchers then analyzed data extracted from the device, including the bradykinesia score (BKS), the dyskinesia score (DKS), the percent time tremor (PTT), and the fluctuation and dyskinesia score (FDS).

The BKS and DKS scores are calculated by two algorithms incorporated in the PKG device and indicate the likelihood scores for the two complications. The PTT indicates the percentage of device-reading time in which patients experienced tremors, while the FDS is a summary score of motor fluctuations and dyskinesias.

In addition to PKG data, patient scores were analyzed on several validated measures of Parkinson’s motor symptoms, including the total scores of the Unified Parkinson’s disease rating scale part III (UPDRS III, motor examination), the UPDRS III-bradykinesia scores, the UPDRS III-rigidity scores, and the Wearing-off Questionnaire-9 (WOQ-9) scores. The WOQ-9 screens for the wearing off of medications, particularly levodopa.

Statistical analyses showed that BKS scores for bradykinesia obtained from the PKG device were highly correlated with all three UPDRS III scores, especially in the subset of patients who were still at the earlier stages of Parkinson’s.

A correlation also was found between percent time tremor scores, or the time patients experienced tremors, on the data obtained from the PKG device and the UPDRS III tremor scale.

Additionally, the data showed that BKS scores tended to be more serious in patients whose symptoms started, and were more severe, on the left side of their body, than in those whose symptoms started, and were more noticeable, on the right side of their body.

“Our findings support the feasibility of using the PKG to detect abnormal movements, especially bradykinesia in PD [Parkinson’s disease]. It is suitable for the early detection, remote monitoring, and timely treatment of PD symptoms,” the researchers concluded.

PTT貼「武漢公文」救了台灣疫情？黃士修傻眼：最先警告「人傳人」其實就是中共-風傳媒

新冠肺炎（武漢肺炎）在中國爆發之初，台灣政府擔心過去SARS景象重演，因此搶先進行防疫措施和行動，讓疫情得以控制。中央流行疫情指揮中心發言人莊人祥曾透露，台灣如何得知新冠肺炎疫情，進而向世界衛生組織（WHO）示警，全靠疾管署副署長、指揮中心醫療應變組副組長羅一鈞深夜逛PTT，並且發現鄉民所貼的武漢市衛健委通知公文，才讓團隊開始緊急應變。以核養綠發起人黃士修得知消息後表示，這番發言再度證實，首先警示疫情有「人傳人」風險的單位，其實就是中共官方。

黃士修在臉書貼文說道，羅一鈞看到的PTT貼文，「內容其實就是武漢市衛生健康委員會的公文」，這再度證實，如果按照指揮官陳時中的邏輯，首先警示疫情有人傳人風險的單位，其實是中共官方。

他接著說，順帶一提，去（2019）年12月31日的時候，台灣在幹嘛？全民忙著總統大選啊！「台灣本來就在美中角力之下求生存，無論你要叫這個國家什麼名字，你都不應該自甘被任一方拿去當槍使，甚至還沾沾自喜，完全喪失國家主體性。」

黃士修提到，讓他覺得離譜的是，「台灣竟然還是拿中共官方資訊，加入美國跟WHO之間的爭執」，然後台灣鄉民還去出征WHO秘書長譚德塞、出征新加坡總理夫人何晶、出征台裔球星林書豪。

他也盤點支持與反對WHO的國家，「支持WHO的國家包含非洲聯盟55國、東協10國、77國集團（成員國134個）、英國、法國、德國、日本、南韓、中國大陸；反對WHO的國家僅有美國。」

黃士修狠酸，不要奢望槍頭折損之後，美國會為台灣負起任何責任，「永遠不要忘記1979年中美斷交，國際之間只有利益沒有道義。其實國際不是看不到台灣，台灣人的作為，世界各國都在看。為什麼我要『逆時中』出來講話？因為我堅持主張，台灣不能變成在國際上說謊的流氓國家。」

黃士修最後說，「我們的每一言每一行，不是只做給2300萬台灣人民看，同時也做給14億中國大陸人民看，更甚者，做給全世界77億人看。我一向認為自稱台派的人很噁心，因為你們正在幫中共孤立台灣。」